{"id":"W4316506432","doi":"10.1016/j.omtn.2023.01.006","title":"Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice","year":2023,"lang":"en","type":"article","venue":"Molecular Therapy — Nucleic Acids","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Japan Science and Technology Agency; National Center of Neurology and Psychiatry; Precursory Research for Embryonic Science and Technology; Otsuka Pharmaceutical; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Human Frontier Science Program; Nihon Medi-Physics; Japan Agency for Medical Research and Development; Japan Society for the Promotion of Science London; Université Laval","keywords":"Amyotrophic lateral sclerosis; Neurodegeneration; Frontotemporal dementia; Nucleic acid; Oligonucleotide; Systemic administration; In vivo; Medicine; Chemistry; Cytoplasm; Pharmacology; Neuroscience; Cell biology; Cancer research; Biology; Disease; Dementia; Pathology; Biochemistry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005737669,0.0003443678,0.0006027271,0.0004821568,0.0001041632,0.0000371513,0.0002541424,0.0002449581,0.0001180539],"category_scores_gemma":[0.00003979293,0.0003084616,0.0002374109,0.001477016,0.0002332906,0.0001356104,0.00007642984,0.0003680165,0.00002670356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002311983,"about_ca_system_score_gemma":0.0001213076,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004190438,"about_ca_topic_score_gemma":0.000003884421,"domain_scores_codex":[0.9969499,0.0002810516,0.00061296,0.0005839441,0.0008015569,0.000770664],"domain_scores_gemma":[0.998833,0.00004518918,0.0001328625,0.0005876093,0.0002056212,0.000195706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009793398,0.0002771961,0.0004850609,0.00008102621,0.0001841918,0.0001228002,0.001032538,0.001211254,0.9728675,0.0001815591,0.0001111906,0.02246638],"study_design_scores_gemma":[0.01017177,0.001340523,0.06171063,0.0004755571,0.0001206104,0.000126431,0.0009758761,0.01372458,0.90904,0.0006086496,0.0009859367,0.0007194537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941803,0.001910681,0.000380103,0.002024598,0.0001165783,0.001021801,0.00001874754,0.0001503241,0.000196914],"genre_scores_gemma":[0.9969189,0.001931748,0.0003441473,0.0003647856,0.00005563665,0.00002786802,0.00005652402,0.0001299065,0.0001705186],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06382748,"threshold_uncertainty_score":0.9999368,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03795346494441981,"score_gpt":0.3050348720937128,"score_spread":0.267081407149293,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}